agilon health (NYSE:AGL) Shares Up 5.6% After Analyst Upgrade

agilon health, inc. (NYSE:AGL) shares shot up 5.6% during trading on Thursday after Royal Bank of Canada raised their price target on the stock from $3.00 to $3.50. Royal Bank of Canada currently has an outperform rating on the stock. agilon health traded as high as $3.58 and last traded at $3.55. 318,263 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 5,431,873 shares. The stock had previously closed at $3.36.

A number of other research firms also recently weighed in on AGL. Barclays reduced their price target on agilon health from $5.00 to $2.00 and set an “underweight” rating for the company in a research report on Monday, November 11th. TD Cowen reduced their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and boosted their price target for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Wednesday. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $3.95.

Insider Buying and Selling

In related news, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have acquired 77,500 shares of company stock valued at $169,600. 3.20% of the stock is owned by insiders.

Institutional Trading of agilon health

Institutional investors have recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC acquired a new stake in shares of agilon health during the third quarter worth $513,000. Aigen Investment Management LP acquired a new stake in agilon health in the 3rd quarter worth about $79,000. Simplify Asset Management Inc. raised its stake in agilon health by 67.5% in the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock worth $663,000 after purchasing an additional 67,968 shares in the last quarter. Intech Investment Management LLC bought a new stake in agilon health in the 3rd quarter valued at about $228,000. Finally, Citigroup Inc. grew its position in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter.

agilon health Price Performance

The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The company’s fifty day moving average price is $2.91 and its 200 day moving average price is $3.04. The company has a market capitalization of $1.49 billion, a P/E ratio of -3.84 and a beta of 0.66.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.